1. Home
  2. IDCC vs BIO Comparison

IDCC vs BIO Comparison

Compare IDCC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InterDigital Inc.

IDCC

InterDigital Inc.

HOLD

Current Price

$330.29

Market Cap

8.6B

Sector

Miscellaneous

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$305.03

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDCC
BIO
Founded
1972
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Laboratory Analytical Instruments
Sector
Miscellaneous
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
8.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IDCC
BIO
Price
$330.29
$305.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$412.50
$358.50
AVG Volume (30 Days)
257.2K
189.5K
Earning Date
02-05-2026
02-12-2026
Dividend Yield
0.84%
N/A
EPS Growth
58.70
N/A
EPS
14.75
N/A
Revenue
$928,587,000.00
$2,557,500,000.00
Revenue This Year
N/A
$1.62
Revenue Next Year
N/A
$2.26
P/E Ratio
$22.57
N/A
Revenue Growth
28.75
N/A
52 Week Low
$169.87
$211.43
52 Week High
$412.60
$373.69

Technical Indicators

Market Signals
Indicator
IDCC
BIO
Relative Strength Index (RSI) 53.12 40.79
Support Level $301.86 $306.52
Resistance Level $325.44 $316.63
Average True Range (ATR) 13.92 9.57
MACD 2.94 -1.13
Stochastic Oscillator 84.05 14.79

Price Performance

Historical Comparison
IDCC
BIO

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: